To the full analysis
ChemoMetec stock: growth
CHEMM.COChemoMetec reported $75.76M in revenue for fiscal 2026, up 3.1% on the prior year, up 12.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
17.9%
per year from 2007 to 2026, per share 17.9%
Earnings (Annual rate)
33.4%
per year from 2007 to 2026, per share 33.4%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 12.7% | 19.6% | 17.9% |
| Revenue per share | 12.7% | 18.4% | 17.9% |
| Earnings | 18.0% | 34.4% | 33.4% |
| Earnings per share | 18.0% | 33.0% | 33.4% |
| Free cash flow | 16.9% | no data | no data |
| Free cash flow per share | 16.9% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $3.31M | $124.96K | −$1.33M |
| 2008 | $6.64M | $1.96M | −$1.53M |
| 2009 | $4.75M | $681.57K | $255.11K |
| 2010 | $4.83M | −$546.53K | −$457.89K |
| 2011 | $5.52M | $16.01K | −$148.23K |
| 2012 | $5.81M | −$1.46M | $323K |
| 2013 | $6.14M | $51.29K | $173.73K |
| 2014 | $6.7M | $170.47K | −$215.68K |
| 2015 | $9.08M | $1.18M | $653.41K |
| 2016 | $12.63M | $1.55M | −$1.88M |
| 2017 | $13.39M | $1.11M | −$123.48K |
| 2018 | $16.7M | $2.7M | $1.33M |
| 2019 | $26.02M | $6.2M | $4.63M |
| 2020 | $31.74M | $8.77M | $6.71M |
| 2021 | $41.67M | $13.1M | $12.34M |
| 2022 | $63.5M | $23.64M | $17.93M |
| 2023 | $65.87M | $26.48M | $16.8M |
| 2024 | $60.46M | $20.2M | $12.67M |
| 2025 | $73.46M | $27.63M | $26.32M |
| 2026 | $75.76M | $29.92M | $26.99M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = DKK 6.7461)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 31 Jul 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.